David Mardle, UK | Chambers Profiles

Regional Rankings
Global
Asia-Pacific
Brazil
Canada
Europe
France
Greater China Region
Latin America
UK
UK Bar
Germany
USA
Specialist Rankings
NewLaw
Crisis & Risk Management
FinTech
High Net Worth
Litigation Support
Spotlight Rankings
USA: Spotlight
Articles
Global Practice Guides
Expert Focus
Diversity, Equity and Inclusion
Legal Articles
Events
Guide Launch Dates
Upcoming Events
Browse All Events
Event Sponsorship
About Our Events
DEI Events
Amplify your presence
Profile Platform
Amplify your ranking and be more discoverable
Includes:

Online Profile

Referee Management

Research Analytics

Marketing Toolkit

Plaques
Improve your performance
Insight
Improve your ranking with unique market insight
Includes:

Client and Market Intelligence

Client Intelligence

Rankings Data Hub

Business Intelligence
Market PulseNew
Showcase your expertise
Global Practice Guides Contributions
Highlight your subject matter expertise
Expert Focus
Provide commentary on key legal matters
In-depth Overviews
Events Sponsorship
Global Practice Guides
View our latest publications
Elevate your talent strategies
Chambers Talent
Access a range of ways to gain valuable insights to inform talent strategies
Leading Teams
Heighten your understanding of and identify the key drivers of talent retention and motivation
Chambers Student
Chambers Associate
Submissions
Submissions Process
Methodology
Research Schedule
Research Team
Help
My Account

Ranked in 2 Practice Areas

1

Band 1

Private Equity: Venture Capital Investment

UK-wide

18 Years Ranked

3

Band 3

Life Sciences: Transactional

UK-wide

3 Years Ranked

About

Provided by David Mardle

UK

Practice Areas

David Mardle is a partner in Goodwin’s Technology and Life Sciences group and co-chair of Goodwin UK. With 20 years of experience advising on financings and M&A transactions in the life sciences and technology sectors, leveraging his significant M&A experience combined with his general corporate and capital markets expertise, David now concentrates his focus on representing emerging companies providing counsel on corporate and capital markets transactions.

Personal

BA, 1988

University of Oxford

Chambers Review

Provided by Chambers

UK

Private Equity: Venture Capital Investment - UK-wide

1

Band 1

Individual Editorial

David Mardle maintains a destination practice for emerging technology and life sciences companies in their transactional matters. He also offers premier advice to investor clients on financings and M&A.

Learn more about this team❖View ranking table

Life Sciences: Transactional - UK-wide

3

Band 3

Individual Editorial

David Mardle has extensive experience advising clients in the life science and biotechnology sectors on significant M&A and financing matters.

Learn more about this team❖View ranking table

Strengths

Provided by Chambers

David is well respected in the market.

Private Equity: Venture Capital Investment respondent
UK

David has an exceptional ability to clearly communicate and argue complex issues. His pragmatic, commercial advice is based on extensive experience.

Private Equity: Venture Capital Investment respondent
UK

David is hugely experienced and innovative in all areas.

Private Equity: Venture Capital Investment respondent
UK

He’s extremely well known for working on high growth innovation companies.

Private Equity: Venture Capital Investment respondent
UK

David is an excellent counsel on many matters, from financing to investment to commercial execution.

Private Equity: Venture Capital Investment respondent
UK

David is well respected in the market.

Private Equity: Venture Capital Investment respondent
UK

David has an exceptional ability to clearly communicate and argue complex issues. His pragmatic, commercial advice is based on extensive experience.

Private Equity: Venture Capital Investment respondent
UK

David is hugely experienced and innovative in all areas.

Private Equity: Venture Capital Investment respondent
UK

He’s extremely well known for working on high growth innovation companies.

Private Equity: Venture Capital Investment respondent
UK

David is an excellent counsel on many matters, from financing to investment to commercial execution.

Private Equity: Venture Capital Investment respondent
UK

Filter by

East Anglia

Intellectual Property

1

Tim Worden

1

Band 1

Georgia Powell

Associates to watch

London (Firms)

Banking & Finance: Mid-Market

4

Simon Fulbrook

4

Band 4

Commercial and Corporate Litigation

3

Oliver Glynn-Jones

3

Band 3

5

Sarah McAtominey

5

Band 5

Real Estate: £50-150 million

4

Martin Smith

4

Band 4

Restructuring/Insolvency

4

Simon Thomas

4

Band 4

Tax

5

David Irvine

5

Band 5

Matthew Birchall

Associates to watch

Tax: Investment Funds

1

Laura Charkin

1

Band 1

UK-wide

Data Protection & Information Law

Curtis McCluskey

Associates to watch

Employee Share Schemes & Incentives

4

Anna Humphrey

4

Band 4

Healthcare: Corporate/Commercial

4

Sophie McGrath

4

Band 4

Hotels & Leisure

3

Matthew Pohlman

3

Band 3

Investment Funds: Private Equity

2

Michael Halford

2

Band 2

4

Ajay Pathak

4

Band 4

4

Patrick Deasy

4

Band 4

Investment Funds: Private Equity: Secondaries

3

Thiha Tun

3

Band 3

Investment Funds: Real Estate

1

Justin A Cornelius

1

Band 1

U

Bhargavi Mudakavi

U

Up and Coming

20 of 29 results